Antibiotic prophylaxis for Pancreatoduodenectomy with Endoscopic biliary stenting: APE trial
Phase 3
Recruiting
- Conditions
- Pancreatic cancer or other disease that require pa ncreatoduodenectomy
- Registration Number
- JPRN-jRCTs041220033
- Lead Sponsor
- Sugiura Teiichi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 210
Inclusion Criteria
(1) Patients who planned to undergo pancreatoduodenectomy
(2) Patients who performed endoscopic biliary stenting (EBS) for obstructive jaundice
Exclusion Criteria
(1) Patients without preoperative biliary drainage
(2) Patients with bacteria detected in bile culturewithin 2 weeks prior to registration
(3) Patients who planed to undergo total pancreatectomy (including residual total pancreatectomy)
(4) Patients who received preoperativeradiotherapy (with or without chemotherapy)
(5) Patients who planed to undergo combined major hepatectomy (two or more segments)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method